TY  - GEN
AU  - Gaur,Aditya H
AU  - Kizito,Hilda
AU  - Prasitsueubsai,Wasana
AU  - Rakhmanina,Natella
AU  - Rassool,Mohammed
AU  - Chakraborty,Rana
AU  - Batra,Jagmohan
AU  - Kosalaraksa,Pope
AU  - Luesomboon,Wicharn
AU  - Porter,Danielle
AU  - Shao,Yongwu
AU  - Myers,Michael
AU  - Ting,Lillian
AU  - SenGupta,Devi
AU  - Quirk,Erin
AU  - Rhee,Martin S
TI  - Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial
SN  - 2352-3018
PY  - 2017///0609
KW  - Adenine
KW  - administration & dosage
KW  - Adolescent
KW  - Alanine
KW  - Anti-HIV Agents
KW  - Area Under Curve
KW  - CD4 Lymphocyte Count
KW  - Child
KW  - Cobicistat
KW  - Drug Therapy, Combination
KW  - Emtricitabine
KW  - Female
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - genetics
KW  - Humans
KW  - Lost to Follow-Up
KW  - Male
KW  - Quinolones
KW  - RNA, Viral
KW  - blood
KW  - South Africa
KW  - epidemiology
KW  - Tablets
KW  - Tenofovir
KW  - analogs & derivatives
KW  - Thailand
KW  - Uganda
KW  - United States
KW  - Viral Load
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1016/S2352-3018(16)30121-7
ER  -